Navigation Links
Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/11/2011

arned in 2009 and 2010 resulted from the recognition of a portion of the $35 million, upfront, non-refundable license fee under the Bayer agreement and the related reimbursement by Bayer of third-party development costs.  In addition, in 2010, the Company recognized $15.0 million in revenue for the achievement of the first milestone, as well as approximately $0.4 million in sponsored research revenue, under the license agreement with Bayer.  

For the three and twelve months ended December 31, 2010, total operating expenses increased to $17.8 million and $68.6 million, respectively, from $14.4 million and $52.9 million for the same periods in 2009.  Total operating expenses for the three and twelve months ended December 31, 2010 included non-cash stock-based compensation charges of $1.8 million and $10.8 million, or $0.08 per share and $0.49 per share, respectively, as compared to charges of $1.4 million and $5.8 million, or $0.08 per share and $0.32 per share, respectively, for the same periods in 2009. These increased charges were primarily in connection with the departure of certain employees during the third quarter of 2010.  The increase in total operating expenses between the 2009 and 2010 periods was primarily a result of an increase in research and development expense due mainly to the continued development and progression of our clinical and preclinical programs, as well as the above-described increase in non-cash, stock-based compensation expense.

Net loss for the three and twelve months ended December 31, 2010 was $0.6 million and $41.6 million, or $0.03 per share and $1.91 per share, respectively, compared to a net loss for the same periods in 2009 of $6.3 million and $30.9 million, or $0.34 per share and $1.70 per share, respectively.   The decrease in net loss between the three-month periods and the increase in net loss between the twelve-month periods were due primarily to the revenue and operating expen
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
2. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
3. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
4. Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
5. Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference
6. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
7. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
8. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
9. Ardea Biosciences to Present at Two Upcoming Investor Conferences
10. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
11. Ardea Biosciences Prices Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... An article posted earlier this week by Fox News ... probiotics. The article stated that while many products are claiming ... listed, the actual use for probiotics may go beyond ... the total uses of probiotics have not yet been discovered, ... “miracle” bacterium, and debunked the myths surrounding them. , ...
(Date:6/19/2013)... June 19, 2013 ... announced the addition of the "Global ... report to their offering. ... of data protection and old security practises ... have driven the growth of biometric technologies ...
(Date:6/19/2013)... ROCKVILLE, Md. , June 19, 2013 Synthetic ... on the prevention and treatment of serious infectious diseases, announced ... the 6 th Annual OneMedForum New York Conference on ... New York City . Mr. Riley is scheduled ... live webcast of Synthetic Biologics, presentation can be accessed by ...
(Date:6/19/2013)... Calif. , June 19, 2013  Continuing its ... myocardial infarction (MI), Beckman Coulter , Inc. announces ... of its new Access AccuTnI+3 troponin I assay for ... "Clinicians have depended on Beckman Coulter,s ... new AccuTnI+3 assay has the proven performance to continue ...
Breaking Biology Technology:Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3Synthetic Biologics to Present at OneMedForum New York 2013 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3
... 10, 2010 Syngenta and DuPont today announced that ... effective November 8, 2010. The transaction dissolves a joint ... Hi-Bred. It enables Syngenta and Pioneer to pursue independent ... genetics and biotechnology traits. Davor Pisk, ...
... than previously thought, because they can still work with ... according to a study published today in Physical ... step closer to designing and building real-life quantum computing ... a wide range of fields, from drug design, electronics, ...
... 9, 2010 NeoStem, Inc. (NYSE Amex: NBS ... operations in the U.S. and China, today announced that NeoStem,s ... be honored tonight at Moves Magazine,s 2010 Power Women Awards ... Center, 399 Lafayette Street, New York City. ...
Cached Biology Technology:Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 2Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 3Syngenta and DuPont Announce Ownership Change at GreenLeaf Genetics 4Quantum computers a step closer to reality thanks to new finding 2NeoStem Chairman and CEO to be Honored at the Moves 2010 Power Women Awards 2
(Date:6/19/2013)... of the patients who received injections of steroids ... New England Compounding Center has found that some ... not experience a worsening of their symptoms and ... infection, especially among those individuals who received injections ... along with an editorial by UC Davis Assistant ...
(Date:6/19/2013)... June 19, 2013 - The Flemish plant scientist Marc ... Food Prize 2013", jointly with the American scientists Mary-Dell ... Washington DC on Wednesday by the US Secretary of ... "Nobel Prize for food and agriculture" - gives the ... has been of exceptional social importance for the quality, ...
(Date:6/19/2013)... of researchers at the University of Pittsburgh has ... of HIV, that could be potential treatments for ... resistance. These new agents are quite small, making ... was published in the June 2013 issue of ... , The first of many probable applications will ...
Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 2World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 3World Food Prize goes to a Belgian for the first time: The scientist Marc Van Montagu 4HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... By placing quantum dots on a specially designed ... have demonstrated enhanced fluorescence intensity by a factor ... diodes, optical switches and personalized, high-sensitivity biosensors., We ... said Brian Cunningham, a professor of electrical and ...
... rerio) develops one of its four stripes. Their findings ... an important molecule that is involved in the arrangement of ... embryo. The research focused on a particular zebrafish mutant ... four stripes running down its side is missing, and it ...
... can in one fell swoop decode 50 million sequences representing ... led by University of Delaware scientists is working to unmask ... off in rice--a crop vital to the world,s food supply. ... by a $5.3-million grant from the National Science Foundation (NSF), ...
Cached Biology News:Researchers set new record for brightness of quantum dots 2Study shows how the zebrafish gets his stripe 2UD leads $5.3-million research project on rice epigenetics 2UD leads $5.3-million research project on rice epigenetics 3UD leads $5.3-million research project on rice epigenetics 4
... the smallest thermal cyclers on the market, which ... 0.5ml (20 samples) or 0.2ml microtube (25 samples) ... and cooling rate of 3.6C/sec and 2.0C/sec respectively ... Fast track programming with new quick dial facility ...
... HRP Conjugate Stabilizer is an aqueous solution ... other non-toxic stabilizing chemicals in a MOPS ... 6.7. This product contains a combination ... ppm Proclin 300 (Rohm and Haas Company) ...
Preparation Note: Prepared by method of Wimmer, E., et al., Biochemistry, 7, 2623 (1968). Quality Clarifier: Acceptor Activity: approx. 1000 picomoles phenylalanine per A 260 unit (not determined b...
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
Biology Products: